EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Cataplexy‐Like Episodes Following Suvorexant Use in a Non‐Narcoleptic Patient: A Brief Report

Nishat Kulkarni iD, Christina Finch

Journal of Sleep Research · 2026-08 · 35 (4)

DOI: 10.1111/jsr.70310 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Sleep Research, online erschienen am 12.02.2026. Verfasst von Nishat Kulkarni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Triazoles, Azepines, Cataplexy, Sleep Aids, Pharmaceutical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dual orexin receptor antagonists (DORAs) such as suvorexant are effective treatments for insomnia but are associated with rapid eye movement (REM) sleep–related adverse effects. While sleep paralysis and hypnagogic hallucinations are recognised, cataplexy is not typically reported. We describe a 39‐year‐old male US Navy Veteran with chronic pain, long‐standing insomnia and anxiety who developed recurrent, emotionally triggered episodes of bilateral ptosis, slurred speech, unsteadiness and subjective “euphoric” sensations shortly after initiating suvorexant. Neurologic evaluation, electroencephalography, electromyography and brain imaging were unrevealing. Multiple sleep latency testing demonstrated normal mean sleep latency without sleep‐onset REM periods, excluding narcolepsy. Polysomnography revealed mild obstructive sleep apnea. Symptoms diminished substantially following suvorexant discontinuation and multimodal treatment including cognitive behavioural therapy for insomnia, escitalopram and continuous positive airway pressure therapy, though mild residual symptoms persisted. This case suggests that suvorexant may provoke cataplexy‐like phenomena via REM‐intrusion mechanisms in susceptible individuals. Clinicians should monitor for atypical motor or speech symptoms in patients prescribed DORAs, particularly those with psychiatric comorbidity or sleep fragmentation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesAzepinesCataplexySleep Aids, PharmaceuticalOrexin Receptor AntagonistsHumansMaleAdultSleep Initiation and Maintenance DisordersPolysomnography

Stichwörter der Autor:innen

REM sleep intrusioncataplexy mimicinsomniaorexin receptor antagonistssuvorexant

Substanzen

TriazolessuvorexantAzepinesSleep Aids, PharmaceuticalOrexin Receptor Antagonists

Autor:innen und Institutionen

  • Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
  • VA San Diego Healthcare System, San Diego, California, USA.
  • Division of Pulmonary, Critical Care, Sleep Medicine and Physiology, University of California San Diego, La Jolla, California, USA.

ORCID-Profile: Nishat Kulkarni

Zitieren

APA

Kulkarni, N., & Finch, C. (2026). Cataplexy‐Like Episodes Following Suvorexant Use in a Non‐Narcoleptic Patient: A Brief Report. Journal of Sleep Research, 35(4). https://doi.org/10.1111/jsr.70310

Vancouver

Kulkarni N, Finch C. Cataplexy‐Like Episodes Following Suvorexant Use in a Non‐Narcoleptic Patient: A Brief Report. Journal of Sleep Research. 2026;35(4). doi:10.1111/jsr.70310

BibTeX
@article{Kulkarni2026,
  author = {Kulkarni, Nishat and Finch, Christina},
  title = {Cataplexy‐Like Episodes Following Suvorexant Use in a Non‐Narcoleptic Patient: A Brief Report},
  journal = {Journal of Sleep Research},
  year = {2026},
  volume = {35},
  number = {4},
  doi = {10.1111/jsr.70310}
}
Kostenlos starten →